Nesek-Adam Visnja, Grizelj-Stojcić Elvira, Mrsić Viviana, Smiljanić Aleksandra, Rasić Zarko, Cala Zoran
Department of Anesthesiology, Resuscitation, and Intensive Care, Sveti Duh General Hospital, Zagreb, Croatia.
J Laparoendosc Adv Surg Tech A. 2004 Aug;14(4):212-8. doi: 10.1089/lap.2004.14.212.
Postoperative nausea and vomiting (PONV) is one of the most significant problems in laparoscopic surgery. The antiemetic effects of metoclopramide and droperidol used alone or in combination for prevention of PONV after laparoscopic cholecystectomy (LC) were assessed in this prospective, double blind, placebo controlled randomized study.
A series of 140 patients, ASA physical status I or II, were included in the study. Patients were randomized to one of the following groups: 1, placebo; 2, metoclopramide 10 mg after the induction of anesthesia and placebo at 12 h postoperatively; 3, droperidol 1.25 mg after the induction of anesthesia and droperidol 1.25 mg at 12 h postoperatively; and 4, droperidol 1.25 mg plus metoclopramide 10 mg after the induction of anesthesia and droperidol 1.25 mg at 12 h postoperatively. Patients were observed for 24 hours for PONV, pain, need for rescue analgesics, and adverse events.
Data were analyzed using the Student's t-test and chi-square test, with P < 0.05 considered statistically significant. The mean incidence of PONV was 54% with placebo, 42% with metoclopramide, 14% with two doses of droperidol alone, and 11% with a combination of metoclopramide plus droperidol. The patients receiving a combination of metoclopramide and droperidol had a significantly lower rate of PONV than those administered metoclopramide alone (P < 0.05) or placebo (P < 0.001). Those receiving two-dose droperidol alone also had a significantly lower incidence of PONV compared with metoclopramide (P < 0.05) and placebo (P < 0.001). There was no statistically significant difference between the metoclopramide and placebo groups. Sedation was significantly greater in patients administered droperidol 12 h postoperatively.
The combination of metoclopramide and droperidol, and two-dose droperidol alone, were found to significantly decrease the incidence of PONV after LC, whereas metoclopramide alone proved inefficient.
术后恶心呕吐(PONV)是腹腔镜手术中最严重的问题之一。在这项前瞻性、双盲、安慰剂对照的随机研究中,评估了甲氧氯普胺和氟哌利多单独或联合使用对预防腹腔镜胆囊切除术(LC)后PONV的止吐效果。
本研究纳入了140例ASA身体状况为I或II级的患者。患者被随机分为以下几组:1组,安慰剂组;2组,麻醉诱导后给予10 mg甲氧氯普胺,术后12小时给予安慰剂;3组,麻醉诱导后给予1.25 mg氟哌利多,术后12小时给予1.25 mg氟哌利多;4组,麻醉诱导后给予1.25 mg氟哌利多加10 mg甲氧氯普胺,术后12小时给予1.25 mg氟哌利多。观察患者24小时的PONV、疼痛、使用解救镇痛药的需求及不良事件。
采用Student's t检验和卡方检验分析数据,P < 0.05被认为具有统计学意义。安慰剂组PONV的平均发生率为54%,甲氧氯普胺组为42%,单独使用两剂氟哌利多组为14%,甲氧氯普胺加氟哌利多联合组为11%。接受甲氧氯普胺和氟哌利多联合治疗的患者PONV发生率显著低于单独使用甲氧氯普胺的患者(P < 0.05)或安慰剂组(P < 0.001)。单独接受两剂氟哌利多治疗的患者PONV发生率也显著低于甲氧氯普胺组(P < 0.05)和安慰剂组(P < 0.001)。甲氧氯普胺组和安慰剂组之间无统计学显著差异。术后12小时给予氟哌利多的患者镇静作用明显更强。
发现甲氧氯普胺和氟哌利多联合使用以及单独使用两剂氟哌利多可显著降低LC后PONV的发生率,而单独使用甲氧氯普胺则效果不佳。